The inhaled aerosol vaccine is far more effective at inducing protective immune responses than traditional injections, targeting the lungs and upper airways where viruses first enter the body and providing long-lasting protection against respiratory infections.
A team of researchers at McMaster University is working on an inhaled COVID-19 vaccine that offers better protection and is less costly to produce, store and ship.
Vaccine development will play a tremendous role in warding off the next pandemic, says Matthew Miller, Director of the Michael G. DeGroote Institute for Infectious Disease Research.
McMaster logo
McMaster logo
